New Product: Isturisa (osilodrostat phosphate) film coated tablets – all strengths

Osilodrostat phosphate is licensed for the treatment of endogenous Cushing's syndrome in adults; and should be initiated and supervised by physicians experienced in endocrinology with access to facilities for monitoring of cortisol levels.

Source:

electronic Medicines compendium